glp-1 heart attack The cardiovascular effects of receptor agonists beyond obesity and type 2 diabetes: An anti-atherosclerotic action New Mechanisms to Prevent Heart
Description
Early studies suggest semaglutide may help with PMOS-related symptoms like insulin resistance and body size, as well as BMI and waist circumference
For many people, these options can be effective and more accessible while newer medications like retatrutide are still being studied
Add creatine, titrate the dose slowly, and get a baseline DEXA scan
With flexible access and up to 10 CPD hours available, its tailored for clinicians seeking updates without leaving practice
Gut hormone co-agonists for the treatment of obesity: from bench to bedside
